Pharmaceutical Partnering
- Korean Drug Developers Turn to Partnering at Bio USA 2026
A broad slate of Korean pharma and biotech firms used Bio USA 2026 to chase partnering deals, from organoid platforms to stem-cell and CDMO work.
A broad slate of Korean pharma and biotech firms used Bio USA 2026 to chase partnering deals, from organoid platforms to stem-cell and CDMO work.